Sirona Biochem Corp.
SRBCF · OTC
10/31/2023 | 10/31/2022 | 10/31/2021 | 10/31/2020 | |
|---|---|---|---|---|
| Market Cap | $19 | $30 | $45 | $56 |
| - Cash | $1 | $0 | $1 | $2 |
| + Debt | $2 | $0 | $1 | $1 |
| Enterprise Value | $20 | $30 | $45 | $56 |
| Revenue | $0 | $1 | $0 | $0 |
| % Growth | -94.8% | 150.7% | 153.5% | – |
| Gross Profit | -$0 | $1 | $0 | $0 |
| % Margin | -82.7% | 92.5% | 74.3% | 48.8% |
| EBITDA | -$2 | -$4 | -$2 | -$4 |
| % Margin | -6,707.4% | -523.2% | -857.8% | -3,895.5% |
| Net Income | -$3 | -$4 | -$2 | -$4 |
| % Margin | -7,312.4% | -529.5% | -860.5% | -3,910.4% |
| EPS Diluted | -0.01 | -0.015 | -0.01 | -0.018 |
| % Growth | 31.8% | -46.5% | 44.8% | – |
| Operating Cash Flow | -$2 | -$2 | -$2 | -$2 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$2 | -$2 | -$2 | -$2 |